You Are Here: Home > About Arthritis > Arthritis in the News > B.C. expands use of biosimilars to offer coverage for more treatment options

B.C. expands use of biosimilars to offer coverage for more treatment options

British Columbia is improving the sustainability of its PharmaCare program by expanding the use of biosimilars, which will create opportunities for new drug listings and boost existing coverage for patients.

The Arthritis Society is gratified that our patient-focused recommendations to the government have been incorporated into the plan. We will continue to monitor the implementation of this plan to ensure a seamless transition.

Includes quote from Arthritis Society Executive Director for BC & Yukon, Christine Basque.Back to News